89bio's market cap is currently ―. The company's EPS TTM is $-0.71; its P/E ratio is ―; 89bio is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.
